Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1

Conditions

Merkel Cell Carcinoma · Cutaneous Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Moffitt Cancer Center, Tampa, Florida, United States
Contact: Study coordinator (Daniel Segal) · Daniel.Segal@moffitt.org · 813-745-0902
Contact: Principal Investigator (Ahmad Tarhini, MD, PhD)

Study leads

Ahmad Tarhini, MD, PhD
Principal Investigator
Moffitt Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

Solid Tumor · Advanced Cancer · Metastatic Cancer

Abroad (travel likely)RecruitingPHASE1

Tampa, United States · Durham, United States

A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors

Cutaneous Melanoma · Mucosal Melanoma · Cutaneous Squamous Cell Carcinoma (CSCC)

Abroad (travel likely)RecruitingPHASE1

Würzburg, Germany · Münster, Germany

A Study of VET3-TGI in Patients With Solid Tumors

Solid Tumor, Adult · Microsatellite Stable Colorectal Cancer · Head and Neck Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1

Los Angeles, United States · Orange, United States

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Cutaneous Squamous Cell Carcinoma · SCC - Squamous Cell Carcinoma · Basal Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1

Basking Ridge, United States · Middletown, United States